One Stop Shop for All Your Market Research Reports

Global Healthcare Contract Research Outsourcing Market Threats, Analysis, Key Players, Growth, and Forecast 2026

Increasing incidence of clinical trials being conducted in emerging countries is expected to drive growth of global healthcare contract research outsourcing (CRO) market. Contract research outsourcing (CRO) is one of the emerging trends in the global healthcare industry. CRO involves outsourcing of various research activities, previously performed by the manufacturer to a third-party researcher. Moreover, the high cost of having an in-house healthcare research facility not only takes effort, but also time and money. This is creating a demand for healthcare contract research outsourcing (CRO). Furthermore, increasing number companies operating in the pharmaceutical, biotechnology, and medical devices sectors are nowadays outsourcing research activities to contract researchers in order to cut manufacturing and production costs without compromising on the quality of end product. Rising healthcare costs and reducing productivity are key factors driving growth of the global healthcare contract research outsourcing (CRO) market. In addition, emergence of biological therapies, decreasing R&D for new drugs, and patent expires on exclusive drugs are all factors contributing to growth of the global healthcare contract research outsourcing (CRO) market. However, variations in regulatory guidelines, long duration for approval process of new drugs and quality issues within the performed research are key restraints for growth of the global healthcare contract research outsourcing (CRO) market. In addition, unforeseen costs and congeniality issues with third party researchers are factors hampering growth of the global healthcare contract research outsourcing (CRO) market. Increasing incidence of clinical trials being conducted in emerging countries and outsourcing activities by major players to save time and reduce costs are key opportunities for growth of the global healthcare contract research outsourcing (CRO) market. An emerging trend in the global healthcare contract research outsourcing (OCT) market is players in the market are forming alliances to enhance the market presence by providing services over an extensive market space. The global contract research outsourcing (CRO) market report has been segmented on the basis of services, destination research group, and region. The market in North America dominated the global contract research outsourcing (OCT) market in terms of revenue share, owing to highest number of trials undertaken and research outsourced in the region. The market in Europe held the second largest market share of the global contract research outsourcing (OCT) market, followed by Asia Pacific. The Asian CRO market is expected to grow at a rapid rate due to the increasing quest of global companies to explore new avenues and to expand their respective business enterprise. Moreover, growing incidence rate of “Western” diseases such as hypertension, diabetes mellitus and dyslipidemia due to change in sedentary life style and dietary pattern is further expected to propel growth of the global healthcare contract research outsourcing (CRO) market. Market Segmentation: Global contract research outsourcing (CRO) market segmentation by service:
  • Clinical trial services drug discovery services
    • Preclinical Services
    • Phase I trial services
    • Phase II trial services
    • Phase III trial services
    • Phase IV trial (post marketing surveillance) services
  • Regulatory services
  • Medical writing services
  • Clinical data management (CDM) service
  • Others
Global contract research outsourcing (CRO) market segmentation by destination research group:
  • Contract research organizations (CROS)
  • Clinical trial laboratories
  • Academic medical canters (AMCs)
Global molecular imaging devices market segmentation by region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Key players in the global molecular imaging devices market include,
  • Piramal Life Sciences
  • Inventiv Health Inc.
  • Medidata Solutions Inc.
  • Icon Plc.
  • Charles River Laboratories International Inc.
  • Parexel International Corp.
  • Pharmaceutical Product Development Inc.
  • Covance Inc.
  • Quintiles Transnational Corp.
  • LabCorp
Request for Table of Contents
Inquiry Before Buying
Request Sample
To choose the report type and your desired payment method

Share This Report

Our Clients

Latest Market News

Sony Profit Forecast Reaches Record Levels Due to Playstation 4 Popularity

The Sony profit forecast for the year to March, 2018, has rebounded from precious disappointing results. The Japanese electronics company has announced its expectation to achieve record annual profits. The popularity of the Playstation 4 gaming console was particularly emphasized as a major reason for this. Sony has f [...]

Read More
Kobe Steel Scandal: Profit Forecast Scrapped Due to Data Falsification

A Kobe Steel scandal over the falsification of safety data has hit the company hard. The Kobe Steel profit forecast has been scrapped. The Japanese steel company withdrew its profit forecast for the year because the costs of its data falsification activities are not yet fully known. Its interim dividend is also to be c [...]

Read More
UK Car Production Down: Brexit Uncertainty Cited as a Cause

UK car production was down 4% in September, the probable cause being given as Brexit uncertainty. This was in spite of a general growth in Britain’s manufacturing industry. The Markit/CIPS purchasing managers’ index (PMI) for July, August and September were 55.3, 56.9 and 55.9 respectively. While September’s figu [...]

Read More
US Economy to Slow Down According to Natixis Investment Bank

Is the US economy about to slow down? According to French investment bank Natixis it is starting from next year. According to Natixis chief economist, Patrick Artus, there will shortly be a significant slowing down of the US economy. What is the evidence for this, and how will this slowdown take shape? [...]

Read More
Hong Kong Stock Exchange Closes Today: Portent of the Future

The Hong Kong stock exchange closes today after 31 years of trading. The closure is the price paid for the rapid rise in internet and electronic trading. Hong Kong is highly unlikely to be the last stock exchange to become redundant.  As increasing amounts of trading are carried out online, the old stock exchange floo [...]

Read More
Payment Mode
Single User $ 4395
Multi User $6395
Corporate User $9395
About this Report
Report ID 148082
Category
  • Healthcare
Published on Upcoming
Number of Pages NA
Publisher Name Prudour
Overall Rating
"No reviews yet"